On May 21, WuXi XDC fell 3.03% in regular trading, trading at 56.0 HKD/share, with trading volume of 148 million HKD.
Within the Life Sciences Tools & Services sector where WuXi XDC belongs, individual stocks showed divergence. Among sector constituents, JOINN up 6.06%, WuXi AppTec up 1.08%, XtalPi up 0.89%, WuXi Bio down 1.21%, Insilico down 4.86%.
WuXi XDC Biotech is an investment holding company principally engaged in providing comprehensive contract research, development, and manufacturing organization (CRDMO) services for antibody-drug conjugates (ADC) and other bioconjugate drugs. Its services cover discovery, process development, and GMP manufacturing, with operations spanning the domestic market, North America, Europe, and other regions worldwide.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments